Why the study?
Does mean 15-day S100B predict 12-month clinical outcome in patients with subarachnoid aneurysmal hemorrhage?
Does mean 15-day S100B predict 12-month clinical outcome in patients with subarachnoid aneurysmal hemorrhage?
Mean 15-day S100B levels strongly predict 12-month neurological outcomes in patients with subarachnoid aneurysmal hemorrhage, supporting its use as a surrogate marker for brain ischemia.
Answers are grounded in this paper and cite their sources.
May support S100B for prognostication in aneurysmal SAH; hypothesis-generating and requires prospective validation before clinical or trial use.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sanchez-Peña et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: